This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Voiceover actors launch generative-AI and copyright-awareness campaign in Japan

By Toko Sekiguchi ( October 23, 2024, 02:04 GMT | Insight) -- Japanese actors have kick-started a campaign against the unauthorized use of their voices, as the growing use of artificial intelligence-generated voices mimicking famous people adds to the urgency of developing a regulatory frameworkto protect biometric intellectual-property rights. The issue is seen as particularly pressing in Japan, because of the popularity of professional voice actors working on animated productions. However, the actors’ right to protect their voices from being used by AI programs is currently an ambiguous legal domain.Japanese actors have kick-started a campaign against the unauthorized use of their voices, as the growing use of artificial intelligence-generated voices mimicking famous people adds to the urgency of developing a regulatory framework to protect biometric intellectual-property rights....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login